Harpoon Therapeutics, Inc. (25) | Business Operations (7)

Browse by Subcategory

Collaboration Agreements (4)
Development Agreements (3)

Recent Contracts

Amendment No. 1 to Amended and Restated Discovery Collaboration and License Agreement by and between the Registrant and AbbVie, Inc., dated as of August 16, 2021 (Filed With SEC on November 10, 2021)
First Amendment to the Development and Option Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of April 21, 2020 (Filed With SEC on August 5, 2020)
Side Letter Amendment to Development and Option Agreement between the Registrant and AbbVie Biotechnology Ltd., dated April 15, 2020 (Filed With SEC on August 5, 2020)
Amended and Restated Discovery Collaboration and License Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of November 20, 2019 (Filed With SEC on March 12, 2020)
Development and Option Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of November 20, 2019 (Filed With SEC on March 12, 2020)
First Amendment to the Discovery Collaboration and License Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of April 3, 2019 (Filed With SEC on May 9, 2019)
Amendment to CHEF1 Collaboration and License Agreement and Development and Manufacturing Services Agreement between Registrant and AGC Biologics, Inc. (formerly known as CMC ICOS... (Filed With SEC on January 29, 2019)